Lindsey Low - Concepedia

Author

Lindsey Low

University of Cambridge

Also Known As

Lindsey Low

Publications

494

Citations

H-Index

Concepts

All Affiliations

University of Cambridge University of Southampton Pfizer (United States)

About

Lindsey Low is an author at University of Cambridge specializing in biosynthesis, synthetic biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	83
2	Medicine	2	2	192
3	Natural Sciences	2	2	83
4	Biochemistry	2	2	83
5	Biomolecular Engineering	1	1	29

Lindsey Low

Publications

494

Citations

H-Index

Page 1

	Year	Citations
DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer Lindsey Low, Ann Mander, Katy J. McCann, Human Gene Therapy Novel Dna VaccineImmunologyImmunoeditingImmunotherapeuticsImmunotherapy	2009	176
Active-site residue, domain and module swaps in modular polyketide synthases Francesca Del Vecchio, Hrvoje Petković, Steven G. Kendrew, Journal of Industrial Microbiology & Biotechnology	2003	126
Substrate specificity of the acyl transferase domains of EpoC from the epothilone polyketide synthase Hrvoje Petković, Axel Sandmann, Iain R. Challis, Organic & Biomolecular Chemistry Bioorganic ChemistryEngineeringMolecular BiologyChemical BiologyEnzymatic Modification	2007	54
Rapamycin biosynthesis: elucidation of gene product function Matthew A. Gregory, Hui Hong, Rachel E. Lill, Organic & Biomolecular Chemistry	2006	48
Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272 Sabine Gaisser, Laurenz Kellenberger, Andrew L. Kaja, Organic & Biomolecular Chemistry	2003	45
Engineered biosynthesis of hybrid macrolide polyketides containing d-angolosamine and d-mycaminose moieties Ursula Schell, Stephen Haydock, Andrew L. Kaja, Organic & Biomolecular Chemistry Bioorganic ChemistryEngineeringD-mycaminose MoietiesGlycobiologyMolecular Biology	2008	29
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines Ann Mander, Ferdousi Chowdhury, Lindsey Low, Cancer Immunology Immunotherapy VaccinationTumor ImmunologyMedicineImmunological Endpoint AssaysImmunology	2008	16

Page 1